These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 487699)

  • 1. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.
    Monks TJ; Caldwell J; Smith RL
    Clin Pharmacol Ther; 1979 Oct; 26(4):513-24. PubMed ID: 487699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man.
    Monks TJ; Lawrie CA; Caldwell J
    Biopharm Drug Dispos; 1981; 2(1):31-7. PubMed ID: 7236869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metabolic and pharmacokinetic comparison of theophylline and aminophylline (theophylline ethylenediamine).
    Monks TJ; Smith RL; Caldwell J
    J Pharm Pharmacol; 1981 Feb; 33(2):93-7. PubMed ID: 6111606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear theophylline elimination.
    Tang-Liu DD; Williams RL; Riegelman S
    Clin Pharmacol Ther; 1982 Mar; 31(3):358-69. PubMed ID: 7060318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of clinically important interaction between erythromycin and theophylline.
    Hildebrandt R; Gundert-Remy U; Möller H; Weber E
    Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.
    Brion N; Naline E; Beaumont D; Pays M; Advenier C
    Br J Clin Pharmacol; 1989 Mar; 27(3):391-5. PubMed ID: 2497767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mexiletine on elimination and metabolic conversion of theophylline and its major metabolites in rats.
    Ogiso T; Iwaki M; Tanino T; Okuyama K; Uno S
    Biol Pharm Bull; 1993 Feb; 16(2):163-7. PubMed ID: 8364452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5.
    Yu CL; Louie TM; Summers R; Kale Y; Gopishetty S; Subramanian M
    J Bacteriol; 2009 Jul; 191(14):4624-32. PubMed ID: 19447909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug interactions affecting fluoroquinolones.
    Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
    Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental changes in urinary elimination of theophylline and its metabolites in pediatric patients.
    Tateishi T; Asoh M; Yamaguchi A; Yoda T; Okano YJ; Koitabashi Y; Kobayashi S
    Pediatr Res; 1999 Jan; 45(1):66-70. PubMed ID: 9890610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline: a dose-range study.
    Rovei V; Chanoine F; Strolin Benedetti M
    Br J Clin Pharmacol; 1982 Dec; 14(6):769-78. PubMed ID: 7150456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-linear elimination processes of theophylline.
    Gundert-Remy U; Hildebrandt R; Hengen N; Weber E
    Eur J Clin Pharmacol; 1983; 24(1):71-8. PubMed ID: 6832205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.
    Bonnacker I; Berdel D; Süverkrüp R; von Berg A
    Eur J Clin Pharmacol; 1989; 36(2):145-50. PubMed ID: 2721539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative analysis of theophylline and its metabolites in urine of Chinese healthy subjects after oral administration of theophylline sustained-release tablets].
    Liu Y; Zhan Y; Zhang YF; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2014 Jul; 49(7):1039-43. PubMed ID: 25233637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 Jan; 15(1):117-9. PubMed ID: 6849735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline pharmacokinetics in normal elderly subjects.
    Shin SG; Juan D; Rammohan M
    Clin Pharmacol Ther; 1988 Nov; 44(5):522-30. PubMed ID: 3180633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples.
    Zydroń M; Baranowski J; Baranowska I
    J Sep Sci; 2004 Oct; 27(14):1166-72. PubMed ID: 15537072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. I. Single dose administration.
    Madsen SM; Ribel U
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):1-7. PubMed ID: 7223434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluconazole on theophylline disposition in humans.
    Konishi H; Morita K; Yamaji A
    Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.